MORTON COLLINS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MORTON COLLINS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MORTON COLLINS. MORTON COLLINS is Director in SPECIAL DIVERSIFIED OPPORTUNITIES INC. ($SDOI) and Director in KOPIN CORP ($KOPN) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB).
Latest Insider Trading Transactions of MORTON COLLINS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GEB, KOPN, SDOI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Sell | S | 12.48 | 44,000 | 549,120 | 44,500 | 88.5 K to 44.5 K (-49.72 %) |
Feb 23 2021 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Sell | S | 12.70 | 44,500 | 565,150 | 0 | 44.5 K to 0 (-100.00 %) |
Feb 23 2021 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Sell | S | 10.33 | 44,000 | 454,520 | 44,500 | 88.5 K to 44.5 K (-49.72 %) |
Feb 23 2021 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Sell | S | 10.02 | 11,500 | 115,230 | 0 | 11.5 K to 0 (-100.00 %) |
Feb 23 2021 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Sell | S | 10.03 | 21,000 | 210,630 | 0 | 21 K to 0 (-100.00 %) |
Jun 02 2020 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Grant | A | 0.00 | 10,000 | 0 | 130,000 | 120 K to 130 K (+8.33 %) |
May 21 2019 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Grant | A | 0.00 | 10,000 | 0 | 120,000 | 110 K to 120 K (+9.09 %) |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 8,170 | 0 | 0 | |
May 13 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 8,170 | 0 | 168,130 | 160 K to 168.1 K (+5.11 %) |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 8,013 | 0 | 8,013 | |
May 09 2019 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 3.90 | 12,500 | 48,750 | 12,500 | |
Apr 12 2019 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Gift | G | 0.00 | 1,000 | 0 | 1,000 | 0 to 1,000 |
Apr 12 2019 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Gift | G | 0.00 | 1,000 | 0 | 143,000 | 142 K to 143 K (+0.70 %) |
Jul 05 2018 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Grant | A | 0.00 | 10,000 | 0 | 110,000 | 100 K to 110 K (+10.00 %) |
May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 7,669 | 0 | 0 | |
May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 8,170 | 0 | 8,170 | |
May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 4.56 | 12,500 | 57,000 | 12,500 | |
May 14 2018 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 7,669 | 0 | 159,960 | 152.3 K to 160 K (+5.04 %) |
Jun 02 2017 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Grant | A | 0.00 | 10,000 | 0 | 100,000 | 90 K to 100 K (+11.11 %) |
May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 7.14 | 12,500 | 89,250 | 12,500 | |
May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 7,669 | 0 | 7,669 | |
May 15 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 10,000 | 0 | 152,291 | 142.3 K to 152.3 K (+7.03 %) |
Mar 28 2017 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 6.25 | 21,300 | 133,189 | 50,000 | 28.7 K to 50 K (+74.22 %) |
Jun 29 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.13 | 10,000 | 91,309 | 142,291 | 132.3 K to 142.3 K (+7.56 %) |
Jun 29 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.13 | 10,000 | 91,309 | 142,291 | 132.3 K to 142.3 K (+7.56 %) |
May 20 2016 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Buy | P | 1.88 | 31,500 | 59,220 | 31,000 | -500 to 31 K (-6,300.00 %) |
May 20 2016 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Buy | P | 1.88 | 25,000 | 47,000 | 90,000 | 65 K to 90 K (+38.46 %) |
May 16 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 9.33 | 10,000 | 93,300 | 10,000 | |
May 16 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
May 11 2016 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Grant | A | 0.00 | 10,000 | 0 | 65,000 | 55 K to 65 K (+18.18 %) |
May 09 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
May 09 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | M | 0.00 | 5,000 | 0 | 132,291 | 127.3 K to 132.3 K (+3.93 %) |
Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.49 | 28,000 | 265,700 | 64,750 | 36.8 K to 64.8 K (+76.19 %) |
Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.57 | 28,000 | 267,960 | 64,750 | 36.8 K to 64.8 K (+76.19 %) |
Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.46 | 4,200 | 39,720 | 6,650 | 2.5 K to 6.7 K (+171.43 %) |
Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.49 | 2,000 | 18,979 | 6,450 | 4.5 K to 6.5 K (+44.94 %) |
Apr 18 2016 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Buy | P | 9.45 | 6,200 | 58,565 | 28,700 | 22.5 K to 28.7 K (+27.56 %) |
May 11 2015 | KOPN | KOPIN CORP | COLLINS MORTON | Director | Grant | A | 0.00 | 10,000 | 0 | 55,000 | 45 K to 55 K (+22.22 %) |
May 08 2015 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 8.01 | 7,500 | 60,075 | 7,500 | |
May 08 2015 | GEB | INOVIO PHARMACEUTI ... | COLLINS MORTON | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Jan 03 2008 | SDOI | SPECIAL DIVERSIFIE ... | COLLINS MORTON | Director | Grant | A | 0.00 | 3,345 | 0 | 325,062 | 321.7 K to 325.1 K (+1.04 %) |
Jan 03 2007 | SDOI | SPECIAL DIVERSIFIE ... | COLLINS MORTON | Director | Grant | A | 0.00 | 4,761 | 0 | 321,717 | 317 K to 321.7 K (+1.50 %) |
Page: 1